- Stocks Telegraph
- Posts
- 22 Sep - Morning Newsletter (with changes)
22 Sep - Morning Newsletter (with changes)
These 4 Stocks are ready to move!
Good Morning!
This week seems to be the week of central banks. No fewer than four prominent central banks are making interest rate decisions this week. Today we have the SNB (Swiss National Bank) and the BOE (Bank of England), but what we will briefly talk about now is the Fed. Fed chairman Jerome Powelll said in his press conference yesterday that the scaling back of quantitative easing could start in November.To repeat it in exact words: 'The tapering could start from the next FOMC meeting'. This is normally scheduled for November 3. Powell, however, expects no rate hikes to arrive until the tapering is completed. For now, the Fed is still buying $120 billion in mortgage-backed securities per month.The S&P 500 rose 0.95% to 4,395 points. The technology exchange Nasdaq 100 gained 0.99% with a closing price of 15,176 points and the Dow Jones Industrial Average climbed 1.39% on Wednesday. Indices climbed ahead of the FOMC meeting and after the usual volatility during the press conference, futures appear to be slowly continuing their upward trend. Futures on the big three stock indices are up between 0.20% and 0.30% last nightYesterday, the FDA (Food and Drug Administration) announced that it is now possible in the US to give a third vaccination to patients at risk, the over-65s and at-risk professions. However, this is purely an ' emergency-use authorization'. Pfizer-BioNTech is the only vaccine to have received this approval from the FDA to date. There is still no clarity about the approval of Moderna's third vaccine. It is also unclear what should happen to patients at risk who previously received a vaccine other than Pfizer's. At first glance, the news had no impact on Pfizer's stock. Pfizer closed the day with 0.07% gain. Shares of Moderna climbed 1.54%, trading a sloppy 11% below its all-time high.
The Next Tesla?Could THIS be the next TESLA?This private Silicon Valley startup is backed by early investors of Google, Paypal, Uber, and more.It's set to solve a worldwide problem that could help save millions of lives per year...And it could make you up to 10x your money in the coming months.
Today Top Movers
Amplitude Healthcare Acquisition Corporation (AMHC) is up 69.11% to $17.30 in premarket trading today after its shareholders approved the business combination with Jasper Therapeutics.
MEDIROM Healthcare Technologies Inc. (MRM) stock soared 37.36% to $10.15 in the pre-market trading after announcing its major Key Performance Indicators, or KPIs, updated for the month of August 2021.
BlackBerry Limited (NYSE: BB) shares are trading up 8.79% at $10.4 at the time of writing after reporting second quarter fiscal year 2022 results.
Solid Biosciences Inc. (SLDB) grew over 7.33% at $3.22 in pre-market trading today. The company will report positive 1.5-year functional data and patient-reported outcome measures for Patients 4-6 in the ongoing IGNITE DMD Phase I/II clinical trial of SGT-001.
5 stocks that will get you through anythingHow do they do it? Because there is no substitute for what they sell. Everyone buys it, even when money is tight. Including you. You might cancel the Caribbean cruise, but you're not going to stop paying for this. That nonstop demand means they're kicking the tar out of other stocks. Since early 2000, they have posted a 1,636% total return, towering above the S&P 500's 195%.See the 5 stocks here.
Top Upgrades & Downgrades
Piper Sandler turned bullish on Plug Power Inc. (PLUG), upgrading the stock to "Overweight" and assigning a $33.00 price target, representing potential upside of 22.59% from Wednesday's close.
Dada Nexus Limited (DADA) has won the favor of Morgan Stanley's equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $31.60, suggesting 54.15% additional upside for the stock.
argenx SE (ARGX) received an upgrade from analysts at Redburn, who also set their one-year price target on the stock to $381.07. They changed their rating on ARGX to Buy from Neutral in a recently issued research note.
Earlier Thursday JP Morgan reduced its rating on Vipshop Holdings Limited (VIPS) stock to Neutral from Overweight and assigned the price target to $11.00.
JP Morgan analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Eargo Inc. (EAR) has been changed to Underweight from Overweight and the new price target is set at $11.00.
Analysts at Morgan Stanley downgraded Trimble Inc. (TRMB)'s stock to Underweight from Equal Weight Thursday.
Two Powerful Stocks + One Killer Options Strategy For the first time, we reveal our options trading "Dynamic Duo." Get our two most consistent stocks to trade, plus our top options strategy that generates one-day options trades. See how to combine forces for a perfect trading dynamic duo. Trade today, exit tomorrow.
Latest Insider Activity
Hayward Holdings Inc. (HAYW) President, North America ROETKEN RICK announced the sale of shares taking place on Sep 21 at $22.29 for some 12,000 shares. The total came to more than $0.27 million.
Zscaler Inc. (ZS) President of R&D and CTO Sinha Amit sold on Sep 22 a total 72,374 shares at $274.49 on average. The insider’s sale generated proceeds of almost $5.49 million.
aTyr Pharma Inc. (LIFE) Director SCHIMMEL PAUL declared the purchase of shares taking place on Sep 20 at $8.00 for some 250,000 shares. The transaction amount was around $2.0 million.
Myovant Sciences Ltd. (MYOV) 10% Owner Sumitomo Chemical Co., Ltd. bought on Sep 21 a total 49,797,708 shares at $22.48 on average. The purchase cost the insider an estimated $966,451.
#1 Gold Royalty Stock in New Gold Bull Market Revealed Gold is screaming higher and smart investors are Cashing-In on the #1 Gold Investment of 2021-22. Yet, you haven't missed the boat! Trading below $5 per share, it's a leaner, more nimble breed of gold royalty firm. It receives a cut of global gold production without ANY of the risks, or costs, of operating a mine. Its shares would have to rise nearly 100X to match similar predecessor companies.Learn more here...
Important Earnings
Top US earnings releases scheduled for today include NIKE Inc. (NYSE:NKE). It will announce its Aug 2021 financial results. The company is expected to report earnings of $1.11 per share from revenues of $12.46B in the three-month period.
Analysts expect Trip.com Group Limited (NASDAQ:TCOM) to report a net income (adjusted) of $0.06 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Jun 2021 is predicted to come in at $878.09M.
Aehr Test Systems (AEHR), due to announce earnings after the market closes today, is expected to report earnings of -$0.03 per share from revenues of $5.12M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.